Literature DB >> 8050173

Cytokine regulation of low-affinity IgE receptor (CD23) on monocytes from asthmatic subjects.

A Vecchiarelli1, A Siracusa, C Monari, D Pietrella, C Retini, C Severini.   

Abstract

The regulation of CD23 expression (Fc epsilon RII) by cytokines on monocytes from normal subjects, asymptomatic and acute asthmatics was investigated. CD23 was weakly expressed on cells from controls, but was significantly enhanced in the two groups of asthmatics. The addition of IL-4 on monocytes induced an increase of CD23 expression in cells from controls and asthmatics. Interferon-gamma (IFN-gamma) did not modulate CD23 expression in asthmatics or control subjects, while high doses of IL-6 (2000 U/ml) enhanced CD23 expression on cells from asthmatics or controls. In vitro stimulation of monocytes with Timothy grass pollen allergen did not enhance CD23 receptor in asthmatics with a positive skin test to this pollen. We speculate that CD23 expression in asthmatics is markedly enhanced by Th2-dependent cytokines, such as IL-4 and IL-6. Thus, the regulation of Th2 cell activation by anti-cytokine therapy could have an important effect on the down-regulation of CD23 on monocytes, and in shifting a Th2 subpopulation into a Th1 subpopulation by blocking Th2-dependent cytokines.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8050173      PMCID: PMC1534681          DOI: 10.1111/j.1365-2249.1994.tb06076.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  35 in total

1.  IFN-alpha and IFN-gamma have different regulatory effects on IL-4-induced membrane expression of Fc epsilon RIIb and release of soluble Fc epsilon RIIb by human monocytes.

Authors:  A A te Velde; F Rousset; C Peronne; J E De Vries; C G Figdor
Journal:  J Immunol       Date:  1990-04-15       Impact factor: 5.422

Review 2.  A new approach to the treatment of asthma.

Authors:  P J Barnes
Journal:  N Engl J Med       Date:  1989-11-30       Impact factor: 91.245

3.  Atopy in subjects with asthma followed to the age of 28 years.

Authors:  W J Kelly; I Hudson; P D Phelan; M C Pain; A Olinsky
Journal:  J Allergy Clin Immunol       Date:  1990-03       Impact factor: 10.793

Review 4.  A functional dichotomy in CD4+ T lymphocytes.

Authors:  K Bottomly
Journal:  Immunol Today       Date:  1988-09

5.  Soluble CD23 (Fc epsilon RII) and interleukin 1 synergistically induce early human thymocyte maturation.

Authors:  M D Mossalayi; J C Lecron; A H Dalloul; M Sarfati; J M Bertho; H Hofstetter; G Delespesse; P Debre
Journal:  J Exp Med       Date:  1990-03-01       Impact factor: 14.307

6.  Interleukin 4 and soluble CD23 as progression factors for human B lymphocytes: analysis of their interactions with agonists of the phosphoinositide "dual pathway" of signalling.

Authors:  J Gordon; J A Cairns; M J Millsum; S Gillis; G R Guy
Journal:  Eur J Immunol       Date:  1988-10       Impact factor: 5.532

7.  CD23 expression on B-lymphocytes and its modulation by cytokines in allergic patients.

Authors:  M Corominas; M Mestre; J Bas; J Verdaguer; A Valls; A Romeu; E Buendia
Journal:  Clin Exp Allergy       Date:  1993-07       Impact factor: 5.018

8.  Influence of recombinant IL-4, IFN-alpha, and IFN-gamma on the production of human IgE-binding factor (soluble CD23).

Authors:  G Delespesse; M Sarfati; R Peleman
Journal:  J Immunol       Date:  1989-01-01       Impact factor: 5.422

9.  Two species of human Fc epsilon receptor II (Fc epsilon RII/CD23): tissue-specific and IL-4-specific regulation of gene expression.

Authors:  A Yokota; H Kikutani; T Tanaka; R Sato; E L Barsumian; M Suemura; T Kishimoto
Journal:  Cell       Date:  1988-11-18       Impact factor: 41.582

10.  Human recombinant interleukin 4 induces Fc epsilon R2/CD23 on normal human monocytes.

Authors:  D Vercelli; H H Jabara; B W Lee; N Woodland; R S Geha; D Y Leung
Journal:  J Exp Med       Date:  1988-04-01       Impact factor: 14.307

View more
  1 in total

1.  CD23 surface density on B cells is associated with IgE levels and determines IgE-facilitated allergen uptake, as well as activation of allergen-specific T cells.

Authors:  Regina Selb; Julia Eckl-Dorna; Alina Neunkirchner; Klaus Schmetterer; Katharina Marth; Jutta Gamper; Beatrice Jahn-Schmid; Winfried F Pickl; Rudolf Valenta; Verena Niederberger
Journal:  J Allergy Clin Immunol       Date:  2016-05-09       Impact factor: 10.793

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.